A Trial of TTI-621 in Combination With Doxorubicin in Patients With Leiomyosarcoma

Condition:   Leiomyosarcoma Interventions:   Drug: TTI-621;   Drug: Doxorubicin Sponsor:   Trillium Therapeutics Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials